Back to Aptus Capital Advisors, LLC Aptus Capital Advisors, LLC

GILDGILD
25 quarters

Position history for Aptus Capital Advisors, LLCAptus Capital Advisors, LLC's holdings in GILEAD SCIENCES INC

Yes. Aptus Capital Advisors holds 74,929 shares of GILD (Gilead Sciences), worth $9.5M, as of its Q2 2026 13F filing. It reduced the position by 451 shares (-0.6%) from Q1 2026. Aptus Capital Advisors has held GILD since Q3 2022, across 16 quarterly 13F filings. GILD is 0.1% of Aptus Capital Advisors' reported 13F portfolio.

Current Value

$9.5M

Current Shares

74,929

Total Value Change

+$7.4M

Total Shares Change

+43,377

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
74,929
-0.6%
$9.5M0.1%$125.63
0
2026-Q1
Decreased
75,380
-5.5%
$10.5M0.1%$137.68
0
2025-Q4
Increased
79,782
+3.5%
$9.8M0.1%$120.57
29
2025-Q3
Increased
77,080
+241.8%
$8.6M0.1%$108.32
44
2025-Q2
Increased
22,554
+20.8%
$2.5M0.0%$107.45
31
2025-Q1
Increased
18,675
+2.0%
$2.1M0.0%$107.83
26
2024-Q4
Increased
18,301
+121.5%
$1.7M0.0%$88.27
41
2024-Q3
Increased
8,263
+3.9%
$692,7700.0%$79.45
26
2024-Q2
Decreased
7,954
-9.2%
$545,7240.0%$64.42
0
2024-Q1
Decreased
8,761
-85.7%
$641,7440.0%$67.94
0
2023-Q4
Decreased
61,082
-0.1%
$4.9M0.1%$74.37
0
2023-Q3
Decreased
61,162
-3.5%
$4.6M0.1%$68.18
0
2023-Q2
Increased
63,386
+1446.0%
$4.9M0.1%$69.44
52
2023-Q1
Decreased
4,100
-11.4%
$340,1970.0%$74.04
0
2022-Q4
Increased
4,630
+4.3%
$397,4860.0%$75.89
25
2022-Q3
New
4,439
-
$274,0000.0%$54.08
32
2022-Q2
Exited
0
-100.0%
$00.0%$53.58
0
2022-Q1
New
2,869
-
$171,0000.0%$50.90
31
2020-Q3
Exited
0
-100.0%
$00.0%$50.66
0
2020-Q2
Decreased
2,687
-28.8%
$206,0000.0%$61.04
0
2020-Q1
Decreased
3,775
-44.1%
$282,0000.0%$58.79
0
2019-Q4
Decreased
6,755
-77.6%
$438,0000.0%$50.63
0
2019-Q3
Decreased
30,200
-13.1%
$1.9M0.1%$48.92
0
2019-Q2
Increased
34,731
+10.1%
$2.3M0.3%$51.66
34
2019-Q1
First report
31,552
-
$2.1M0.4%$49.25
0

Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used